Literature DB >> 17496937

Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast.

Hassan M Abdalla1, Mona A Sakr.   

Abstract

BACKGROUND AND
PURPOSE: The phyllodes tumor is characterized by its tendency to recur locally and occasionally to metastasize. Local recurrence and death from metastases are occasional, but consistent, theme in reports of patients with phyllodes tumors (PTs). The aim of this study was to determine parameters that influence outcome in this uncommon neoplasm. PATIENTS AND METHODS: Data from 79 patients with phyllodes tumors were reviewed retrospectively, reclassifying the pathological material using the World Health Organization (WHO) criteria.
RESULTS: The median age of the patients was 42 years with a range from 16 to 70 years. The tumor size ranged from 2.5 to 24 cm, with a median of 11 cm. Based on the criteria proposed by WHO, 31 cases were benign tumors (39.2%), 27 borderline tumors (34.2%), and 21 malignant tumors (26.6%). The median duration of follow up was 60 months ranging from 3 to 138 months. Following local excision, the local recurrence rates were 14.3%, 50%, and 75% in patients with benign, borderline, and malignant tumors; respectively, while after wide local excision the local recurrence rates were 0%, 36.3% and 40%; respectively. Whereas, 0%, 8.3%, and 8.3% of patients with benign, borderline and malignant tumors; respectively, locally recurred after mastectomy. The 5-year disease free survival was 63.3% after local excision, 70% after wide local excision, and was 87% after mastectomy (p=0.04). Distant metastases (DM) were recorded in 10 patients (12.6%) after a median duration of 14 months (range 3- 36). All cases with DM died after an average of 5 months with a range of 1 to 11 months. Distant metastases developed in 3.2%, 11.1%, and in 28.6% of patients with benign, borderline and malignant tumors; respectively. The 5-year survival with no evidence of disease was 90% for the patients with benign tumors compared to 69% for borderline and 61% for malignant PTs (p= 0.02).
CONCLUSIONS: The histotype of phyllodes tumors and resection margins were the principal determinants of local recurrence and distant metastases. Complete surgical excision by either wide local excision or mastectomy if necessary is important in the primary surgical treatment of phyllodes tumors.

Entities:  

Mesh:

Year:  2006        PMID: 17496937

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  25 in total

1.  Phyllodes tumor of the breast.

Authors:  Grzegorz Korpanty; Derek G Power; Conleth Murphy; Malcolm Kell; John McCaffrey
Journal:  Med Oncol       Date:  2010-10-02       Impact factor: 3.064

2.  Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: A systematic review and meta-analysis.

Authors:  Shiyan Zeng; Xindan Zhang; Dejuan Yang; Xiaoyi Wang; Guosheng Ren
Journal:  Mol Clin Oncol       Date:  2015-02-06

3.  Radiotherapy in Phyllodes Tumour.

Authors:  Sunitha Susan Varghese; Balukrishna Sasidharan; Marie Therese Manipadam; M J Paul; Selvamani Backianathan
Journal:  J Clin Diagn Res       Date:  2017-01-01

4.  Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast.

Authors:  Valerie Cui Yun Koh; Aye Aye Thike; Nur Diyana Md Nasir; George Wai Cheong Yip; Boon Huat Bay; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

5.  Surgical margins for borderline and malignant phyllodes tumours.

Authors:  A Thind; B Patel; K Thind; J Isherwood; B Phillips; K Dhaliwal; D D Remoundos
Journal:  Ann R Coll Surg Engl       Date:  2020-01-10       Impact factor: 1.891

6.  Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.

Authors:  Philip M Spanheimer; Melissa P Murray; Emily C Zabor; Michelle Stempel; Monica Morrow; Kimberly J Van Zee; Andrea V Barrio
Journal:  Ann Surg Oncol       Date:  2019-02-19       Impact factor: 5.344

Review 7.  Width of margins in phyllodes tumors of the breast: the controversy drags on?-a systematic review and meta-analysis.

Authors:  Arnaud Toussaint; Romain Piaget-Rossel; Coraline Stormacq; Patrice Mathevet; Karine Lepigeon; Patrick Taffé
Journal:  Breast Cancer Res Treat       Date:  2020-09-15       Impact factor: 4.872

8.  A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors.

Authors:  Richard J Barth; Wendy A Wells; Sandra E Mitchell; Bernard F Cole
Journal:  Ann Surg Oncol       Date:  2009-05-08       Impact factor: 5.344

Review 9.  Phyllodes tumours of the breast: a consensus review.

Authors:  Benjamin Y Tan; Geza Acs; Sophia K Apple; Sunil Badve; Ira J Bleiweiss; Edi Brogi; José P Calvo; David J Dabbs; Ian O Ellis; Vincenzo Eusebi; Gelareh Farshid; Stephen B Fox; Shu Ichihara; Sunil R Lakhani; Emad A Rakha; Jorge S Reis-Filho; Andrea L Richardson; Aysegul Sahin; Fernando C Schmitt; Stuart J Schnitt; Kalliopi P Siziopikou; Fernando A Soares; Gary M Tse; Anne Vincent-Salomon; Puay Hoon Tan
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

10.  Value of Conventional MRI Texture Analysis in the Differential Diagnosis of Phyllodes Tumors and Fibroadenomas of the Breast.

Authors:  Nianping Jiang; Li Zhong; Chunlai Zhang; Xiangguo Luo; Peng Zhong; Xiaoguang Li
Journal:  Breast Care (Basel)       Date:  2020-06-23       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.